Top Markets
Coin of the day
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc.

TFFP
Rang in Aktien #40710
Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals,... Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals, Inc., leverages its proprietary Thin Film Freezing (TFF) technology platform for the advancement and commercialization of therapeutic products across the United States and Australia. A primary emphasis is placed on creating inhaled dry powder formulations to address various pulmonary ailments and disorders. Its two leading drug candidates, both currently in Phase II clinical trials, include TFF Voriconazole Inhalation Powder, designed to combat invasive pulmonary aspergillosis, and TFF Tacrolimus Inhalation Powder, aimed at preventing lung transplant rejection. Beyond these, the company's pipeline features other dry powder products like a cannabidiol substance targeting various epilepsy syndromes, anxiety, insomnia, and pain; an Inhaled SARS-CoV2 Monoclonal Antibody for COVID-19 patients; Niclosamide Inhalation Powder, intended for human tapeworm infections and COVID-19; and a range of other vaccines. Strategic partnerships are also central to its operations, including a licensing arrangement with the University of Texas at Austin for inhaled dry powder drug development, a joint development pact with Augmenta Bioworks, Inc. for the inhaled SARS-CoV2 monoclonal antibody, and a broad licensing and collaboration agreement with UNION therapeutics A/S. Established in 2018, the company maintains its headquarters in Austin, Texas.
Aktienkurs
$0.065
Zuletzt synchronisiert: 2025-01-10
Marktkapitalisierung
$94.10K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel TFF Pharmaceuticals, Inc. (TFFP)

Kategorie

Preis TFFP mit Marktkapitalisierung von B
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
TFFP
$0.065
Marktkapitalisierung von TFF Pharmaceuticals, Inc.(TFFP)
Marktkapitalisierung: $94.10K
Mit Stand August 2026 hat TFF Pharmaceuticals, Inc. eine Marktkapitalisierung von $94.10K. Das macht TFF Pharmaceuticals, Inc. laut unseren Daten zum 40710th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von TFF Pharmaceuticals, Inc. von 2019 bis 2026
TFFP im Vergleich zu den Top 5 der beliebtesten stocks
Preis für TFFP Vermögenswert B Marktkapitalisierung von B Ergebnisse
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$3,775,383 $94.10K
$5.466T +5,808,281,050.57%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$3,076,998 $94.10K
$4.455T +4,733,843,527.74%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$2,881,403 $94.10K
$4.171T +4,432,927,968.98%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$2,546,097 $94.10K
$3.686T +3,917,072,030.09%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$1,978,073 $94.10K
$2.864T +3,043,188,662.48%